CTSO
Cytosorbents·NASDAQ
--
--(--)
--
--(--)
CTSO fundamentals
Cytosorbents (CTSO) Revenue Breakdown: Q3 2025 Business & Regional Performance
Cytosorbents (CTSO) reported total revenue of 9.48M USD in Q3 2025, with its core business segment Product contributing 100.00%. Regionally, United States remained the largest market, accounting for 0.30% of total revenue. Explore Cytosorbents's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Cytosorbents (CTSO) reported total revenue of 9.48M USD in Q3 2025, with its core business segment Product contributing 100.00%. Regionally, United States remained the largest market, accounting for 0.30% of total revenue. Explore Cytosorbents's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What factors drove the changes in Cytosorbents's revenue and profit?What guidance did Cytosorbents's management provide for the next earnings period?What were the key takeaways from Cytosorbents’s earnings call?What is Cytosorbents's latest dividend and current dividend yield?What were the key takeaways from Cytosorbents's earnings call?Did Cytosorbents beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Cytosorbents year over year?What is Cytosorbents's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
